20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

The Expanding Peptide Therapy Pipeline for Weight Management: Beyond GLP-1

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting the advancement of pharmaceutical science, particularly in the realm of metabolic health. The field of peptide therapy for weight management is rapidly evolving, moving beyond single-target agonists to more complex and effective multi-agonist approaches. This expansion of the peptide therapy for weight management landscape offers new hope for individuals facing the challenges of obesity.

While GLP-1 receptor agonists have shown considerable success, the next generation of obesity treatments involves targeting multiple hormonal pathways. Dual agonists, such as those combining GLP-1 and GIP actions (like Tirzepatide) or GLP-1 and glucagon (like Survodutide), have demonstrated enhanced weight loss and metabolic benefits compared to single agonists. Furthermore, triple agonists, exemplified by Retatrutide, which targets GLP-1, GIP, and glucagon receptors, are showing even more profound effects on weight reduction.

Beyond these incretin-based therapies, research is also exploring other peptide hormones that play a role in appetite regulation and energy balance. Amylin analogues, for instance, are being investigated for their potential to increase satiety and improve glucose metabolism. The comprehensive exploration of these various peptide targets reflects the intricate nature of weight regulation and the growing understanding of the interplay between different hormones.

NINGBO INNO PHARMCHEM CO.,LTD. plays a vital role in this dynamic field by supplying high-quality peptides and intermediates essential for research and development. As the future obesity drug research continues to uncover new therapeutic targets and formulations, the demand for these specialized compounds will grow. The expanding pipeline, encompassing a diverse range of peptide-based strategies, signifies a promising future for the effective management of obesity, offering tailored solutions for a complex health challenge.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Rise of Oral GLP-1 Agonists: A New Era for Obesity Treatment Accessibility

Next: Decoding the Obesity Drug Pipeline: Key Players and Their Mechanisms of Action

All Rights Reserved